Meningioma grading: an analysis of histologic parameters
- PMID: 9414189
- DOI: 10.1097/00000478-199712000-00008
Meningioma grading: an analysis of histologic parameters
Abstract
Histologic grading of meningiomas has prognostic and sometimes therapeutic implications, but diagnostic criteria for atypical meningioma are vague, and the significance of brain invasion in the determination of malignancy remains controversial. We reviewed our experience with 581 patients whose meningiomas were resected at Mayo Clinic during the years 1978 through 1988. All patients were followed until death or a median of 9.0 years. Ten histologic parameters were assessed and compared with recurrence-free survival. On univariate analysis, six variables were associated with recurrence, although most were statistically significant only in the subset of patients having undergone gross total tumor resection. On multivariate analyses, the most significant parameters were histologic brain invasion (when assessable) and maximal mitotic rate of at least four per 10 high-power fields (HPF). Also significant were combinations of at least three of the following four parameters: hypercellularity, architectural sheeting, macronucleoli, and small cell formation. Proposed grading criteria based on these findings yielded 81% classic, 15% atypical, and 4% brain invasive meningiomas with respective 5-year recurrence rates of 12%, 41%, and 56%. There was no association between histologic grade and either extent of surgical resection or patient age. However, male sex was associated with high-grade (atypical/brain invasive) tumors. Too few frankly anaplastic meningiomas were encountered for statistical analysis. Brain invasion and an increased mitotic index (at least four per 10 HPF) are the most powerful histologic factors prognostic for recurrence in meningiomas. We propose an objective definition for atypical meningioma based on our data. Because the difference in recurrence rates for brain invasive and atypical meningiomas was not statistically significant, it could not be determined whether brain invasion alone warrants a designation of malignancy. Likewise, we were unable to determine what constitutes histologic anaplasia due to the rarity of such cases.
Similar articles
-
"Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.Cancer. 1999 May 1;85(9):2046-56. doi: 10.1002/(sici)1097-0142(19990501)85:9<2046::aid-cncr23>3.0.co;2-m. Cancer. 1999. PMID: 10223247
-
Brain Invasion in Meningiomas: Incidence and Correlations with Clinical Variables and Prognosis.World Neurosurg. 2016 Sep;93:346-54. doi: 10.1016/j.wneu.2016.06.055. Epub 2016 Jun 22. World Neurosurg. 2016. PMID: 27344043
-
Atypical Meningiomas: Histologic and Clinical Factors Associated With Recurrence.World Neurosurg. 2019 May;125:e248-e256. doi: 10.1016/j.wneu.2019.01.056. Epub 2019 Jan 24. World Neurosurg. 2019. PMID: 30684705
-
Atypical and malignant meningiomas: a clinicopathological review.Neurosurgery. 1993 Dec;33(6):955-63. doi: 10.1227/00006123-199312000-00001. Neurosurgery. 1993. PMID: 8134008 Review.
-
Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis.Brain Tumor Pathol. 2021 Apr;38(2):81-95. doi: 10.1007/s10014-020-00390-y. Epub 2021 Jan 6. Brain Tumor Pathol. 2021. PMID: 33403457
Cited by
-
Vaccination for invasive canine meningioma induces in situ production of antibodies capable of antibody-dependent cell-mediated cytotoxicity.Cancer Res. 2013 May 15;73(10):2987-97. doi: 10.1158/0008-5472.CAN-12-3366. Epub 2013 Mar 7. Cancer Res. 2013. PMID: 23471847 Free PMC article.
-
Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies.Virchows Arch. 2019 Jan;474(1):87-96. doi: 10.1007/s00428-018-2458-2. Epub 2018 Sep 29. Virchows Arch. 2019. PMID: 30267302
-
Integrative assessment of brain and bone invasion in meningioma patients.Radiat Oncol. 2019 Jul 29;14(1):132. doi: 10.1186/s13014-019-1341-x. Radiat Oncol. 2019. PMID: 31358024 Free PMC article. Clinical Trial.
-
Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification.J Neurol Neurosurg Psychiatry. 2006 Jun;77(6):767-73. doi: 10.1136/jnnp.2005.077974. Epub 2005 Nov 23. J Neurol Neurosurg Psychiatry. 2006. PMID: 16306156 Free PMC article.
-
Chordoid meningioma, an uncommon variant of meningioma: a clinicopathologic study of 12 cases.J Neurooncol. 2006 Jul;78(3):263-9. doi: 10.1007/s11060-005-9092-y. Epub 2006 Apr 21. J Neurooncol. 2006. PMID: 16628477
MeSH terms
LinkOut - more resources
Full Text Sources
Medical